
Loading, please wait...

Loading, please wait...

A systematic review of educational interventions designed to improve inhaler technique in asthma and COPD found that most interventions could produce a meaningful improvement in technique. The review included dozens of interventions delivered through different educational formats, with repeated evidence that clinician demonstration, patient re-demonstration, and structured education can change inhaler use. However, the effect was not always durable, and technique could deteriorate over time. The practical implication is highly relevant to routine respiratory care: inhaler technique should be checked repeatedly, especially when symptoms remain uncontrolled or when therapy is being escalated. Simply telling a patient how to use an inhaler at the time of first prescribing is rarely enough. For HCPs, the best workflow is usually teach–demonstrate–return-demonstrate–reinforce, with attention to the specific device the patient actually uses. The review supports the conference’s emphasis on correcting inhaler technique before stepping up therapy in airway disease. It also illustrates a broader principle of chronic respiratory medicine: implementation quality can determine whether a pharmacologically effective treatment produces the expected clinical benefit.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A systematic review of educational interventions designed to improve inhaler technique in asthma and COPD found that most interventions could produce a meaningful improvement in technique. The review included dozens of interventions delivered through different educational formats, with repeated evidence that clinician demonstration, patient re-demonstration, and structured education can change inhaler use. However, the effect was not always durable, and technique could deteriorate over time. The practical implication is highly relevant to routine respiratory care: inhaler technique should be checked repeatedly, especially when symptoms remain uncontrolled or when therapy is being escalated. Simply telling a patient how to use an inhaler at the time of first prescribing is rarely enough. For HCPs, the best workflow is usually teach–demonstrate–return-demonstrate–reinforce, with attention to the specific device the patient actually uses. The review supports the conference’s emphasis on correcting inhaler technique before stepping up therapy in airway disease. It also illustrates a broader principle of chronic respiratory medicine: implementation quality can determine whether a pharmacologically effective treatment produces the expected clinical benefit.
4 weeks back

A bioengineered oral nanozyme microsupplement converts pathological ROS into a protective polydopamine hydrogel shield. By curbing neutrophil extracellular traps and balancing T cells, this platform outperforms standard 5-ASA in preclinical colitis models, opening new paths for sustained remission.
3 days back

Recent research reveals that downregulating YAP1/TAZ-TEAD via Hippo signaling triggers spontaneous human trophoblast syncytialization in 3D cultures, illuminating placental biology and preeclampsia.
4 weeks back

Abdominal aortic aneurysm rupture remains a catastrophic vascular emergency. Groundbreaking research reveals that USP53 accelerates aneurysm progression by reprogramming smooth muscle cell metabolism toward aerobic glycolysis, highlighting a promising target beyond conventional diameter-based surveillance.
4 days back

A breakthrough study leverages natural language processing to accurately identify incident medication-related osteonecrosis of the jaw and track antiresorptive drug holidays from clinical narratives in electronic health records, advancing osteoporosis pharmacovigilance and dental safety.
4 days back

Recent research defines ferro-aging as a conserved iron-lipid axis driving organ decline across primates. Age-related iron dyshomeostasis stimulates ACSL4-mediated lipid peroxidation, promoting cellular senescence. Notably, vitamin C directly inhibits ACSL4, suppressing phospholipid oxidation and multi-organ decay.
5 days back